Molecular predictors of response to first-line systemic therapies in advanced hepatocellular carcinoma.

被引：0
|
作者：
Chang, Jeremy
Conner, Elizabeth
Fowler, Kathryn J.
Tamayo, Pablo
Burgoyne, Adam
机构：
[1] Univ Calif San Diego, La Jolla, CA USA
[2] Univ Calif San Diego, San Diego, CA USA
[3] Univ Calif San Diego, Dept Radiol, San Diego, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期
关键词：
261-566-9263; 261-566-3248-9542-427-2615; 130-540-543-4790; 3282-270-11593; 283-424-425; 261-566-11347; 3282-206-3691-2722; 8; 6; 4; 3; 1854; 182; 7; 38092-33627; 38092-29187; 38092-20072; 38092-21191; 38092-34303; 2; 1;
D O I：
10.1200/JCO.2024.42.3_suppl.534
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：534 / 534
页数：1
相关论文
共 50 条
  • [41] Cost-effectiveness of sorafenib as a first-line treatment for advanced hepatocellular carcinoma
    Zhang, Pengfei
    Yang, Yu
    Wen, Feng
    He, Xiaofeng
    Tang, Ruilei
    Du, Zedong
    Zhou, Jing
    Zhang, Jian
    Li, Qiu
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 27 (07) : 853 - 859
  • [42] Recent Advances in Systemic Therapies for Advanced Hepatocellular Carcinoma
    Aitcheson G.
    Pillai A.
    Dahman B.
    John B.V.
    Current Hepatology Reports, 2021, 20 (1) : 23 - 33
  • [43] Advances in novel systemic therapies for advanced hepatocellular carcinoma
    Carloni, Riccardo
    Rizzo, Alessandro
    Cusmai, Antonio
    Palloni, Andrea
    Di Federico, Alessandro
    Di Marco, Mariacristina
    Massafra, Raffaella
    Fanizzi, Annarita
    Palmiotti, Gennaro
    Brandi, Giovanni
    FUTURE MEDICINAL CHEMISTRY, 2022, 14 (20) : 1455 - 1470
  • [44] The Current Landscape of Systemic Therapies for Advanced Hepatocellular Carcinoma
    Rana P.
    Haydek J.
    Pillai A.
    Current Hepatology Reports, 2019, 18 (4) : 371 - 382
  • [45] Systemic therapy for advanced hepatocellular carcinoma: targeted therapies
    Tella, Sri Harsha
    Kommalapati, Anuhya
    Mahipal, Amit
    CHINESE CLINICAL ONCOLOGY, 2021, 10 (01)
  • [46] Current and Emerging First-Line Systemic Therapies in Clear Cell Renal Cell Carcinoma
    Rini, Brian I.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (02) : 115 - 117
  • [47] Predictors of extrahepatic recurrence after transarterial chemoembolization as first-line therapy for hepatocellular carcinoma
    Pinto, Elisa
    Pelizzaro, Filippo
    Vitale, Alessandro
    Giannini, Edoardo
    Trevisani, Franco
    Farinati, Fabio
    JOURNAL OF HEPATOLOGY, 2023, 78 : S511 - S512
  • [48] Predictors of extrahepatic recurrence after transarterial chemoembolization as first-line therapy for hepatocellular carcinoma
    Pinto, E.
    Pelizzaro, F.
    Vitale, A.
    Giannini, E. G.
    Trevisani, F.
    Farinati, F.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S51 - S52
  • [49] Tolerability of first line systemic therapy in elderly patients with advanced hepatocellular carcinoma
    Manfredi, Giulia Francesca
    Di Benedetto, Davide
    Acquaviva, Antonio
    Baorda, Francesca
    De Benedittis, Carla
    Gerevini, Chiara
    Rigamonti, Cristina
    Burlone, Michela
    Pirisi, Mario
    JOURNAL OF HEPATOLOGY, 2023, 78 : S599 - S599
  • [50] Advanced hepatocellular carcinoma. Review of targeted molecular drugs
    Pinheiro Alves, Rogerio Camargo
    Alves, Daniele
    Guz, Betty
    Matos, Carla
    Viana, Monica
    Harriz, Michele
    Terrabuio, Deborah
    Kondo, Mario
    Gampel, Otavio
    Polletti, Paula
    ANNALS OF HEPATOLOGY, 2011, 10 (01) : 21 - 27
12345